patients with zoster associated pain
Conditions
Interventions
epidural group: zoster patients received the current standard treatment for herpes and continuous epidural block for 14 days (continuous epidural block : continuous infusion of 4mL/h of 0.1% ropivacai
Sponsors
Korea University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) acute herpes zoster patients 2) PHN patients
Exclusion criteria
Exclusion criteria: 1) past or current conditions that could affect the interpretation of the study results, safety, and subject participation including neurological, psychological, cardiac, hepatic, hematological, muscular, dermatological, or genital problems, cancer, or an immunocompromised state; 2) dermatological diseases other than PHN; 3) a medical history of a recent major procedure or surgery; 4) major pain with a cause other than PHN; 5) the presence of a medical device implanted for neuropathic pain such as a spinal cord stimulator, intrathecal pump, or peripheral nerve stimulator; 6) a medical history of spinal bone surgery, which could complicate catheter migration or application; 7) lactating or pregnant women; and 8) patients judged as inappropriate candidates for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain relief score (VAS reduction) | — |
Secondary
| Measure | Time frame |
|---|---|
| complete remission rate, recurrence rate | — |
Countries
Asia(except Japan)
Contacts
Public ContactJung Eun Kim
Korea University Guro Hospital Department of Anesthesiology and Pain Medicine
Outcome results
None listed